In the world of cannabinoid research, alongside CBD and THC, other cannabinoids are becoming increasingly important, including cannabigerol (CBG). Although less well-known, CBG is being explored across various research areas, with a particular focus on how it interacts with the body's pain pathways. In this blog post, we take a detailed look at the role of CBG flowers in pain-related research and discuss why it is described as a promising direction in the study of modern pain modulation.
For a complete primer, see our pillar guide: What is CBG? Effects, benefits and the difference from CBD.
CBG: an overview of the cannabinoid
CBG, often referred to as the mother of all cannabinoids, is a non-psychoactive cannabinoid present in young cannabis plants. Unlike THC and CBD, CBG is produced in smaller amounts in the plant, which has so far limited extraction and research. Nevertheless, CBG has attracted attention for its potential research properties, including studies that have explored anti-inflammatory pathways and pain modulation. Early studies suggest that CBG interacts with various receptors in the body that are involved in pain regulation and inflammatory responses, making it an interesting candidate for further pain-related research.
Cannabigerol (CBG) is one of more than 100 identified cannabinoids in the Cannabis Sativa plant and is often described as the mother cannabinoid. This is because CBG serves as a precursor to other cannabinoids such as CBD, THC and CBC. In young cannabis plants, CBG is found in relatively high concentrations, but as the plant matures, it is converted into other cannabinoids through natural processes. As a result, most mature cannabis plants contain only a small amount of CBG, usually less than 1%. This makes the extraction and production of CBG-based products more challenging and often more expensive than those based on CBD or THC.
CBG has recently gained scientific interest because of its various potential research properties. Studies have explored whether CBG may have anti-inflammatory, pain-modulating and neuroprotective relevance. Some research has examined whether CBG could be relevant in the context of conditions such as inflammatory bowel diseases, glaucoma and neurodegenerative disorders. CBG acts on the body's endocannabinoid system, similar to CBD and THC, but has a unique interaction with the CB1 and CB2 receptors, which may lead to different research observations. Additionally, there are indications that CBG has antibacterial properties and could even be relevant in research on resistant bacterial strains such as MRSA. These are research directions, not medical claims.
Although research on CBG is still in its early stages, especially compared with CBD and THC, the findings so far are promising. Scientists continue to explore the full research potential of CBG, particularly its role in studies of chronic pain modulation, inflammation, certain tumour cells and neurological conditions. The challenge is to develop efficient and cost-effective methods for extracting and producing CBG so that it becomes more accessible as a research subject. In the coming years, we may see an increase in clinical studies and broader study of CBG in medical research, making this cannabinoid an interesting area for future development.
CBG in pain research
The interest in CBG in the context of pain comes from its ability to interact with the body's endocannabinoid system. This system plays a central role in modulating pain signals and inflammatory responses. CBG appears to act particularly on the CB2 receptors of the endocannabinoid system, which are distributed in peripheral tissues of the body and play an important role in pain modulation. By activating these receptors, CBG could be relevant in research on pain relief and inflammation reduction without producing the psychoactive effects of THC. This makes it particularly interesting for researchers studying natural cannabinoid-based approaches that avoid the psychotropic effects of THC.
Cannabigerol (CBG), a non-psychoactive cannabinoid contained in the Cannabis sativa plant, is increasingly the subject of research for its potential role in pain modulation. Compared to its better-known counterpart CBD (cannabidiol), CBG offers a unique chemical structure and acts in different ways in the body. Early research suggests that CBG has a stronger affinity for the cannabinoid receptors CB1 and CB2, which could give it a potentially stronger effect in pain modulation studies. This is particularly relevant for the study of chronic pain conditions, where conventional approaches are often insufficient or have undesirable side effects.
CBG could play an important role in research on chronic and neuropathic pain in particular. Neuropathic pain caused by nerve damage is often difficult to study and does not respond well to traditional pain-management research. CBG has been shown to influence the activity of neurotransmitters and inflammatory mediators that play a role in the creation and maintenance of pain signals. In addition, CBG appears to have neuroprotective properties that researchers are studying in the context of relieving pain caused by nerve damage. These properties make CBG a promising candidate for the development of new pain research, particularly for difficult-to-study pain syndromes.
Despite CBG's potential in pain research, work in this area is still in the early stages. One of the main obstacles is the lower availability and higher cost of extracting CBG from the cannabis plant, as it is present in smaller amounts than other cannabinoids. Future research will need to focus on clinical studies to determine the efficacy, safety and optimal dosage of CBG as a research subject. In addition, advances in agricultural and extraction technology are needed to make CBG more accessible and economically viable. However, given the growing interest in natural and alternative approaches to pain study, CBG could play an increasingly important role in the future landscape of pain research. Lucky Hemp does not sell CBG as a pain treatment.
Benefits of CBG compared to other cannabinoids
One of the main potential benefits of CBG compared with other cannabinoids such as CBD and THC is its broad research potential with reported low side effects. CBG is being studied not only for its potential pain-modulating and anti-inflammatory properties, but also for its potential neuroprotective, antibacterial and anti-anxiety relevance. Compared to THC, CBG has no psychoactive properties, which makes it a safe option for users who want to avoid impairment of their cognitive functions. Furthermore, CBG may show a synergistic effect in combination with other cannabinoids, known as the entourage effect, which research is exploring in the context of potential therapeutic study.
Cannabigerol (CBG) differs from other cannabinoids such as CBD and THC through its unique interaction with the body's endocannabinoid system (ECS). While CBD and THC primarily bind to CB1 and CB2 receptors in the ECS, CBG shows a different affinity and mode of action. It acts as a kind of modulator of the ECS, influencing the uptake of other cannabinoids and potentially enhancing their effects. This property makes CBG particularly interesting for medical research, as it offers the possibility of studying ways to improve the relevance of cannabinoid-based research without increasing the psychoactive effects of THC.
One of the most notable potential properties of CBG is its potentially stronger anti-inflammatory effects compared with other cannabinoids. Early studies suggest that CBG may effectively influence inflammatory responses in the body, making it a promising candidate for research on chronic inflammatory conditions such as ulcerative colitis or Crohn's disease. Compared with traditional anti-inflammatory approaches, which often have significant side effects, CBG could offer a more natural alternative subject for research.
In addition to its anti-inflammatory properties, CBG also shows neuroprotective effects, which make it interesting for research into neurodegenerative diseases such as Huntington's chorea or Parkinson's disease. It could help in research on slowing neuronal degradation and supporting the quality of life of affected individuals. Furthermore, CBG shows promising antibacterial properties, particularly against bacterial strains resistant to conventional antibiotics. These diverse potential medical research uses of CBG distinguish it from other cannabinoids and make it an exciting area for future therapeutic study.
Use and dosage of CBG
The use of CBG in research contexts can take various forms, including oils, capsules and topical creams. CBG flowers can also be smoked or vaporised. The optimal way to use CBG can vary depending on individual needs, the type and severity of the issue, and specific response to the cannabinoid. It is recommended to start with a low amount and adjust gradually. As with any supplement, users should consult a medical professional, especially if they are already taking medication or have a health condition.
Cannabigerol (CBG), like other cannabinoids, is available in different forms suited to different uses. The most common forms are oils, tinctures, capsules and topical products such as creams and ointments. CBG oils and tinctures are particularly appreciated because they allow easy dosing and quick absorption by the body. Topical applications are great for localised issues such as skin irritation or local sore spots because they can be applied directly to the affected areas. For those who prefer a precise, measurable amount, CBG capsules can be a good choice. Regardless of the form, it is important to start with products made from high-quality, pure CBG extracts.
The correct amount of CBG can vary considerably from person to person, depending on factors such as weight, metabolism, health condition and the specific use. Since there is no universally recommended dose for CBG, it is advisable to start with a low amount and increase gradually until the desired effect is reached. A common starting amount might be between 5 and 10 mg of CBG and can be adjusted based on the user's needs and tolerance. It is important to carefully monitor the body's response to taking CBG and adjust the amount if necessary.
When using CBG, users should consider some important aspects. First, it is advisable to consult a doctor or qualified health advisor before using CBG products, especially if you are already taking other medications or have health issues. In addition, users should pay attention to the quality and purity of CBG products. Products from reputable manufacturers with transparent information about ingredients and manufacturing processes are preferable. Finally, it is important to inform yourself about the legal aspects of CBG use in your region, as laws regarding cannabis and its derivatives may vary.
Legal aspects and availability of CBG
The legal situation of CBG is similar to CBD and varies by country and region. In many countries, CBG is legal as long as it is derived from hemp and the THC content is below the legal limit. The availability of CBG-based products is growing, but due to the lower concentration of CBG in the cannabis plant, these products can be more expensive than CBD-based products. Anyone interested should make sure to buy CBG from reliable sources and verify the quality and purity of the products. It is advisable to check local laws and regulations regarding the purchase and use of CBG products to ensure compliance with local rules.
Conclusion and outlook
CBG flowers offer a promising approach within modern cannabinoid research. With their potential relevance to relieving pain and reducing inflammation in research models, they could represent a valuable subject in studies alongside traditional pain-management research. While further research is needed to understand and validate the full range of CBG's research properties, the findings to date are promising. In an era where interest in natural and holistic study methods is growing, CBG flowers could play an important role in the future of pain-related research. To dive deeper into the basics, read our CBG vs CBD guide. Lucky Hemp sells CBG flowers as a hemp product for adult consumers; we do not sell CBG as a treatment for any condition.
